Hyperthyroidism
📧 Sign up to get email alerts when something new happens for Hyperthyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-12-19FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental NDA for Propylthiouracil submitted by Endo USA, Inc., updating the labeling to reflect the approved changes.…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy [Phase 1, Phase 2]
The document reports results from a completed Phase 1/2 trial evaluating subantimicrobial-dose doxycycline for Graves' ophthalmopathy (Grave…
-
FDA approval · 2012-07-11FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for methimazole filed by Strides Pharma Science Limited.
-
FDA approval · 2012-07-11FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for methimazole submitted by Chartwell RX, LLC under ANDA 040411. This action implements modific…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: Coexisting Thyroid Disease and Hyperparathyroidism
This completed clinical trial investigated the coexistence of thyroid disease and hyperparathyroidism, with hyperthyroidism listed as the co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-03-07FDA Approved: METHIMAZOLE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s original application for methimazole, a generic antithyroid medication used to treat hyperthyroi…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Maternal Autoimmune Thyroid Disease and Fetal Thyroxin
This entry reports a completed clinical trial from the University of Belgrade investigating maternal autoimmune thyroid disease and fetal th…
-
FDA approval · 2011-10-13FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propylthiouracil from Actavis Pharma, Inc., under the ANDA pathway.
-
FDA approval · 2011-10-03FDA Approved: HICON — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for HICON (Sodium Iodide I-131) from Jubilant Radiopharma, updating the product labeling to reflect …
-
FDA approval · 2011-09-23FDA Approved: HICON — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
The FDA approved a supplemental application for HICON (Sodium Iodide I-131) from Jubilant DraxImage Inc., dba Jubilant Radiopharma. The appr…
-
FDA approval · 2011-08-22FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)
The FDA approved a supplemental ANDA for propylthiouracil from Quagen Pharmaceuticals LLC, authorizing the marketing of an additional generi…
-
FDA approval · 2011-08-22FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for methimazole submitted by Chartwell RX, LLC. This action updates the product's labeling/manufactu…
-
FDA approval · 2011-07-27FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Propylthiouracil from Endo USA, Inc., approving changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter
This clinical trial update reports the incidence of thyroid cancer among 4,474 patients treated for hyperthyroidism or goiter.
-
CLINICAL_TRIALS research · 2011-06-20Clinical Trial Update: Thyroid Hormones Effect on Brown Adipose Tissue
An update on a clinical trial investigating the effects of thyroid hormones on brown adipose tissue in individuals with hyperthyroidism.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Early Administration of L-carnitine in Hemodialysis Patients [Phase 3]
A Phase 3 clinical trial evaluating early administration of L-carnitine in hemodialysis patients has completed.
-
FDA approval · 2011-03-28FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for methimazole submitted by Chartwell RX, LLC.
-
FDA approval · 2011-01-21FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propylthiouracil by Actavis Pharma, Inc., indicating a labeling update under the already app…
-
FDA approval · 2010-12-29FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved a supplemental application for Propylthiouracil from Quagen Pharmaceuticals LLC (ANDA).
-
FDA approval · 2010-12-15FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propylthiouracil from Actavis Pharma, Inc., for the generic drug Propylthiouracil.
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Postoperative Hyperthyroidism
The Heidelberg University-sponsored clinical trial investigating postoperative hyperthyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: The Effect of Radioactive Iodine Administration for Thyroid Diseases on H.Pylori Eradication
This clinical trial update reports on the effect of radioactive iodine treatment for thyroid diseases on the eradication of Helicobacter pyl…
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Treatment of M.Graves With Radioactive Iodine: Follow-up Study
Follow-up study evaluating radioactive iodine treatment for Graves' disease causing hyperthyroidism.
-
FDA label_change · 2008-01-17FDA Approved: HICON — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for HICON (Sodium Iodide I-131) from Jubilant Radiopharma, updating its labeling.
-
FDA approval · 2007-12-14FDA Approved: METHIMAZOLE — Original Application (NORTHSTAR RX LLC)
FDA approved NorthStar RX LLC's original ANDA for methimazole, a generic antithyroid medication used to treat hyperthyroidism.